83923-11-9 Usage
Description
Lanthionine ketimine is a natural but nonproteogenic amino acid found in mammalian brain. It is the cyclic thioether analog of Cystine (C995000). It possesses neuroprotective, neuritigenic, and anti-inflammatory activities, making it a potential candidate for the treatment of neurodegenerative diseases.
Uses
Used in Pharmaceutical Industry:
Lanthionine ketimine is used as a neuroprotective agent for its ability to protect neurons from damage and degeneration, which is particularly beneficial in the treatment of neurodegenerative diseases.
Used in Neuroregeneration Applications:
Lanthionine ketimine is used as a neuritigenic factor to promote the growth and regeneration of nerve cells, aiding in the recovery process for patients with neurological disorders.
Used in Anti-inflammatory Treatments:
Lanthionine ketimine is used as an anti-inflammatory agent to reduce inflammation in the brain and nervous system, which can contribute to the progression of neurodegenerative diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 83923-11-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,3,9,2 and 3 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 83923-11:
(7*8)+(6*3)+(5*9)+(4*2)+(3*3)+(2*1)+(1*1)=139
139 % 10 = 9
So 83923-11-9 is a valid CAS Registry Number.
InChI:InChI=1/C6H7NO4S/c8-5(9)3-1-12-2-4(7-3)6(10)11/h3H,1-2H2,(H,8,9)(H,10,11)
83923-11-9Relevant articles and documents
LANTHIONINE-RELATED COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISEASES
-
Page/Page column 69, (2008/06/13)
The present invention provides compositions comprising lanthionine ketimine derivatives and thiomorpholine dicarboxylic acid derivatives, as well as processes for the preparation of such compounds. The invention also concerns the use of lanthionine, lanthionine ketimine (LK), LK derivatives, thiomorpholine dicarboxylic acid (TMDCA), and TMDCA derivatives. It concerns the use of these compounds for the treatment and/or prevention diseases, including diseases affecting the central nervous system. The invention provides for compounds and methods having antioxidant, anti-neuroinflammatory and neuroprotective activities. It also provides for compounds having the ability to pass through and/or be transported through cellular membranes, such the blood-brain barrier.
